Lexaria Bioscience (LEXX) EPS (Diluted) (2014 - 2026)
Lexaria Bioscience (LEXX) EPS (Diluted) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.19 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.15 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Lexaria Bioscience | 10.63 Mn | 7.01 Mn | - | 1.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 0.08 |
| Feb 28, 2026 | 0.06 |
| Nov 30, 2025 | 0.07 |
| Aug 31, 2025 | 0.15 |
| May 31, 2025 | 0.21 |
| Feb 28, 2025 | 0.15 |
| Nov 30, 2024 | 0.16 |
| Aug 31, 2024 | 0.18 |
| May 31, 2024 | 0.13 |
| Feb 29, 2024 | 0.06 |
| Nov 30, 2023 | 0.13 |
| Aug 31, 2023 | 0.18 |
| May 31, 2023 | 3.98 |
| Feb 28, 2023 | 2.16 |
| Nov 30, 2022 | -2.91 |
| Aug 31, 2022 | -2.44 |
| May 31, 2022 | -3.95 |
| Feb 28, 2022 | 2.37 |
| Nov 30, 2021 | -3.31 |
| Aug 31, 2021 | -1.95 |